Driehaus Capital Management’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Driehaus Capital Management’s Portfolio KYTH Stock Details KYTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-53,069	Closed	-$2.11M	–	686
2014 Q1	$2.11M	Sell	53,069 -15,525	-23%	-$694K	0.07%	326
2013 Q4	$2.56M	Buy	68,594 +19,730	+40%	+$818K	0.09%	269
2013 Q3	$2.23M	Buy	48,864 +17,516	+56%	+$524K	0.09%	261
2013 Q2	$848K	Buy	+31,348	New	+$717K	0.04%	356

Other funds holding KYTH

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Driehaus Capital Management's KYTH Position: Q2 2014 in Review

Driehaus Capital Management sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q2 2014, closing a stake of 53,069 shares — an estimated $2.11M sold.

Driehaus Capital Management first reported a position in KYTH in Q2 2013 and held it in 4 quarters. The position peaked at $2.56M in Q4 2013. 104 funds tracked by Wall St. Rank hold KYTH as of Q2 2014.

Driehaus Capital Management reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q2 2014 after selling out during the quarter.
Driehaus Capital Management sold 53,069 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q2 2014, an estimated $2.11M.
Driehaus Capital Management first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q2 2013 and held it in 4 quarters.
Driehaus Capital Management's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $2.56M in Q4 2013.
104 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q2 2014.

Based on Driehaus Capital Management's 13F filing for Q2 2014, filed 14 Aug 2014.